110 related articles for article (PubMed ID: 472621)
21. Development of the ratio of levonorgestrel, 0.15 mg, to ethinyl estradiol, 0.03 mg.
Christie T
J Reprod Med; 1983 Jan; 28(1 Suppl):63-5. PubMed ID: 6403701
[No Abstract] [Full Text] [Related]
22. [Effects and side-effects of 2 estrogen-lynesterenol combinations used in hormonal ovulation inhibition].
Jacobs C; Heinen G; Schmal E
Med Welt; 1974 Sep; 25(35):1351-3. PubMed ID: 4419263
[No Abstract] [Full Text] [Related]
23. Oral contraceptives: clinical problems and choices.
Jones DE; Halbert DR
Am Fam Physician; 1975 Oct; 12(4):115-23. PubMed ID: 1163414
[No Abstract] [Full Text] [Related]
24. Effect of various oral contraceptive combinations on dysmenorrhea.
Milsom I; Andersch B
Gynecol Obstet Invest; 1984; 17(6):284-92. PubMed ID: 6745736
[TBL] [Abstract][Full Text] [Related]
25. [Oral contraceptives and risk of myocardial infarction].
Sørensen MB; Ottesen BS
Ugeskr Laeger; 2002 Apr; 164(18):2415-6. PubMed ID: 12024850
[No Abstract] [Full Text] [Related]
26. Incidence of hyperprolactinemia during oral contraceptive therapy.
Reyniak JV; Wenof M; Aubert JM; Stangel JJ
Obstet Gynecol; 1980 Jan; 55(1):8-11. PubMed ID: 7352067
[TBL] [Abstract][Full Text] [Related]
27. [Lybrel and menstrual cessation].
Nau JY
Rev Med Suisse; 2007 May; 3(110):1209. PubMed ID: 17564351
[No Abstract] [Full Text] [Related]
28. Choosing contraceptive steroids and doses.
Briggs MH
J Reprod Med; 1983 Jan; 28(1 Suppl):57-62. PubMed ID: 6834349
[TBL] [Abstract][Full Text] [Related]
29. Ethinyl estradiol/drospirenone (Yasmin): a newer oral contraceptive.
Somma MA
Am Fam Physician; 2004 May; 69(10):2425-6. PubMed ID: 15168965
[No Abstract] [Full Text] [Related]
30. Oral contraception, 1986. Focus on Triphasil.
Ellsworth H
J Reprod Med; 1986 Jun; 31(6 Suppl):559-64. PubMed ID: 3522896
[TBL] [Abstract][Full Text] [Related]
31. Clinical experience with an ethinyl estradiol-desogestrel oral contraceptive.
Van Trappen Y; Duvivier P; Thiery M; Van Kets H; Defoort P; Parewijck W; Derom R; Kermans G; Schoofs P
Arzneimittelforschung; 1989 Jun; 39(6):717-9. PubMed ID: 2528355
[TBL] [Abstract][Full Text] [Related]
32. [Oral contraceptives: 30 vs 20 micrograms of ethinyl estradiol (EE)].
Urdinola J
Adv Contracept; 1994 Jul; 10 Suppl 1():41-9. PubMed ID: 7839871
[No Abstract] [Full Text] [Related]
33. [A clinical study of the triphasic contraceptive Tri-Regol].
Rachev E
Akush Ginekol (Sofiia); 1995; 34(2):64-5. PubMed ID: 8651433
[No Abstract] [Full Text] [Related]
34. [Contraceptives and breast cancer (author's transl)].
Mauvais-Jarvis P; Kuttenn F
Contracept Fertil Sex (Paris); 1976 Sep; 4(5):343-8. PubMed ID: 992191
[No Abstract] [Full Text] [Related]
35. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial.
Harada T; Momoeda M; Taketani Y; Hoshiai H; Terakawa N
Fertil Steril; 2008 Nov; 90(5):1583-8. PubMed ID: 18164001
[TBL] [Abstract][Full Text] [Related]
36. Oral contraception and thromboembolism: the role of progestogens.
N Z Med J; 1980 Aug; 92(665):98, 101. PubMed ID: 6933346
[TBL] [Abstract][Full Text] [Related]
37. [Changes in plasma levels of androgens and SHBG in patients with polycystic ovary syndrome (PCOs) treated with oral contraceptives containing desogestrel].
Negri P; D'Errico G; Minisci N; Tomasi A
Minerva Ginecol; 1988 Dec; 40(12):699-707. PubMed ID: 2977429
[TBL] [Abstract][Full Text] [Related]
38. Examination of the rebound effect of biphasic oral contraceptives.
Kovács I
Ther Hung; 1990; 38(3):110-3. PubMed ID: 2284619
[TBL] [Abstract][Full Text] [Related]
39. [Possible interference of synthetic estroprogestins with thyroid hormone production].
Paggi A; Leri O; Evangelista M; Manfredi F; Coarelli C; Loiacono C; Cassone R
Clin Ter; 1981 Aug; 98(4):349-63. PubMed ID: 7285541
[No Abstract] [Full Text] [Related]
40. Oral contraceptives: selection of the proper pill.
Dickey RP; Dorr CH
Obstet Gynecol; 1969 Feb; 33(2):273-87. PubMed ID: 5775187
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
